Table 3

Multivariate analysis of the prognostic factors associated with survival in pancreatic adenocarcinoma (nā€‰=ā€‰101)
Independent factors Univariate P Multivariate P Hazard ratio 95% Confidence interval
Pn (Neg/Pos) 0.002 0.002 2.313 1.376-3.889
pv (Neg/Pos) 0.045 0.370 1.342 0.705-2.557
Hepatic metastases (Neg/Pos) 0.000 0.051 2.558 0.998-6.555
pStage (I/II/III, IV) 0.000 0.925 1.041 0.450-2.407
CD44v6 expression (Neg/Pos) 0.010 0.281 1.869 0.600-5.824
CD44v9 expression (Neg/Pos) 0.047 0.718 0.748 0.155-3.603
CD44s expression (Neg/Pos) 0.032 1.000 1.000 0.437-2.287
CD44v6,v9 expression (Neg/Pos) 0.014 0.809 0.809 0.146-4.486
CD44v6,s expression (Neg/Pos) 0.000 0.003 2.602 1.390-4.870
CD44v9,s expression (Neg/Pos) 0.000 0.810 0.808 0.142-4.587

The bold values indicate P-values less than 0.05 in multivariate analysis, pN pathological node stage, pV pathological vessel status, pStage TNM stage (UICC), s CD44s, Neg negative, Pos positive.

Li et al.

Li et al. Diagnostic Pathology 2014 9:79   doi:10.1186/1746-1596-9-79

Open Data